Navigation Links
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
Date:6/7/2009

NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Novo Nordisk (NVO) data presented today at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sugar and weight after two years of treatment.

In the study, 58% of patients treated with liraglutide 1.8 mg once daily reached and maintained the ADA's blood sugar target of A1C less than 7% versus 37% of patients treated with glimepiride 8 mg once daily.

"The fact that liraglutide continues to effectively lower blood sugar after two years of treatment is consistent with its other long-term clinical benefits such as continued reductions in fasting blood sugar and weight," said Dr. Alan Garber, Baylor College of Medicine, Houston, a LEAD(TM) 3 principal study investigator. "Even with available treatments, many type 2 diabetes patients still struggle to control their blood sugar, while losing weight. Liraglutide represents an important advance for these patients."

The LEAD(TM) 3 extension study also documented that treatment with liraglutide leads to early and lasting weight loss. Many currently available diabetes treatments lead to weight gain, a concern for type 2 diabetes patients, most of whom are already overweight. After two years of treatment with 1.8 mg of liraglutide, mean body weight decreased significantly (-2.7 kg) compared to overall weight increase in the glimepiride group (+1.1 kg).

Hypoglycemia is a condition where blood sugar levels become too low. Minor hypoglycemia was more than six times less frequent in the liraglutide treatment groups compared with the glimepiride group.

About LEAD(TM) 3 Extension

The LEAD(TM) 3 Extension compared the efficacy and safety of liraglutide (1.8 mg and 1.2 mg, once daily) to glimepi
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
2. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
3. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
4. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
5. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
6. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
7. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
8. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
9. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
10. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
11. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)...  Web Industries, Inc., a leading provider of ... Device, Advanced Composites, Consumer Products, and Wire & ... Specialties Preferred Converter by 3M,s Medical Specialties business ... streamline their supply chains by using Web as ... intermediate converting services, and contract manufacturing and assembly ...
(Date:3/3/2015)... 2015 Registration is officially open for MEDTEC China ... at the Shenzhen Convention & Exhibition Center. The ... to join the MEDTEC China family of events. MEDTEC China ... to better serve the South China ... an important region for China,s medical ...
(Date:3/3/2015)... Md. , March 3, 2015 /PRNewswire/-- ViaCyte, Inc., a ... islet replacement therapy for the treatment of diabetes in ... Eugene Brandon , Director of Strategic Relations and Project ... showcases the latest in type 1 diabetes management technology ... as follows: , , , Title:   , ...
Breaking Medicine Technology:Web Industries Receives 3M Preferred Converter Status 2Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3ViaCyte to Present at JDRF TypeOneNation Research Summit 2
... MUNDELEIN, Ill., Sept. 10 Sysmex America, Inc. ... information systems developer, today announced that Laboratory Corporation ... ) has signed a five-year agreement for Sysmex ... for LabCorp,s primary testing laboratories.  Implementation of the ...
... ALTO, Calif., Sept. 10 Varian Medical Systems (NYSE: ... November 2 at the annual meeting of  the American Society ... and members of the financial community are invited to join ... a tour of the company,s exhibition at ASTRO. ...
Cached Medicine Technology:Sysmex America Announces LabCorp Hematology Automation Agreement 2Varian Medical Systems Schedules Investor Meeting and Fiscal Year End Review at ASTRO in San Diego, November 2, 2010 2
(Date:3/3/2015)... (PRWEB) March 03, 2015 Findings could ... Researchers at UC Davis have developed and characterized a ... cells, causing them to self-destruct. This novel mechanism was ... for a usually fatal type of brain cancer – ... , The article, to be published in the ...
(Date:3/3/2015)... VA (PRWEB) March 03, 2015 Today ... the Portland-based maker of bike, skate, snow, water, and ... awareness about brain injury. The partnership kicks off with ... website at http://www.nutcasehelmets.com to BIAA during the ... Month. , Each year BIAA leads the nation in ...
(Date:3/3/2015)... US Air Purifiers LLC , an Illinois based ... to announce that all Rabbit brand air purifiers are back ... west coast port strikes. This news comes just in time, ... The port strikes, which have caused significant supply ... growth by as much as 1%, have hindered the restocking ...
(Date:3/3/2015)... DePuy Pinnacle hip lawsuits (( ... the artificial hip system caused recipients to suffer ... in the federal multidistrict litigation underway in U.S. ... the most recent Master Case List issued by ... hip replacement lawsuits are now pending in the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 With a ... Georgia Health Policy Center (GHPC) has been named a ... (RWJF) to support the Bridging for Health: Improving Community ... regions, states and communities improve health and reduce disparities ... grant will support the work of the center and ...
Breaking Medicine News(10 mins):Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) ... a large hospital, more patients died, a new study discovered. ... nursing shortages and cost-cutting, in that the focus should shift ... research, appearing in the March 17 issue of the ...
... Washington, DC Stephen J. Teach, MD, MPH, Medical Director ... pediatric asthma care and research at Children,s National Medical Center, ... that may advance asthma treatment and outcomes, specifically for inner-city ... the National Institutes of Health (NIH) were published and released ...
... Reporter , WEDNESDAY, March 16 (HealthDay News) -- ... city children with the respiratory condition, and almost eliminated ... When added to standard asthma treatments, Xolair (omalizumab) decreased ... control, according to the study, which is published in ...
... It is no surprise to scientists that the largest social ... their face is fundamental to our social interactions, one of ... how our brain processes facial identity. In a ... scientists used an original approach a method that "shakes" ...
... State University shows that while the number of visits to ... park operations has been significantly reduced. The reduction in funding ... $20 billion in economic impact that state parks have on ... for operations puts stress on America,s state-park systems," says Dr. ...
... , AUGUSTA, Ga. A clinical trial using an all-natural ... percent of American adults, is under way at Georgia Health ... are as dry as if you,ve closed the faucet, and ... Stephen Hsu, Molecular and Cell Biologist and co-investigator of the ...
Cached Medicine News:Health News:When Nurse Staffing Drops, Mortality Rates Rise: Study 2Health News:Stephen J. Teach, MD, MPH, part of landmark study on pediatric asthma 2Health News:Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study 2Health News:Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study 3Health News:Innovative technique gives vision researchers insight into how people recognize faces 2Health News:Study shows attendance at state parks grows, even as funding decreases 2Health News:Clinical trial for dry mouth funded by international oral care award 2
... Deluxe hinged knee brace provides ... all types of sports and ... contoured rubber pads to support ... patellar buttress and hyperextension stop. ...
... Knee Orthosis Custom-fitted static-progressive ... contractures. Goniometer version has ... exposed metal contacts skin. ... laundry bag. One size ...
... designed to treat children's injuries (ages 1 to ... compression to minimize hemarthrosis and swelling, and cold ... of the cuff, it can be utilized effectively ... patient. The Pediatric Ankle Cryo/Cuff is ideal for ...
... Unique in the Cryo/Cuff line, the ... cuff is filled directly with water and ... To ensure the optimal amount of compression, ... pressure after application. The cuff remains cold ...
Medicine Products: